Show&Tell #4: Gastrointestinal cancers
- Watch this Show & Tell on Gastrointestinal cancers.
- Dr Andrew J. Wroe, Director of Proton Physics, and Dr Adeel Kaiser, Radiation Oncologist, will share c...
Published in the Red Journal, this study identified patients who benefit most from PBT in terms of predicted 30-year absolute mortality risks (AMR30) from...
In this guideline document, the dosimetric data and clinical evidence of PBT for esophageal cancer (EC) was summarized and evaluated. The clinical outcome data...
AMIT MAITY, MD, PhD Executive Vice-Chair Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia "Proton FLASH Radiation...
A randomized trial comparing proton therapy with transarterial chemoembolization (TACE) for hepatocellular carcinoma, reported a trend toward improved local...
A systematic review examined clinical outcomes and toxicities of proton therapy for gastrointestinal neoplasms. The findings include that proton therapy was...
Another study by the group from New York Proton Center (ProBeam) assessed the feasibility of FLASH RT using single-energy transmission PBS plans of 4.5 Gy × 15...